Nicholas Ieronimakis
Madigan Army Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Nicholas Ieronimakis.
Scientific Reports | 2017
Andrew S. Thagard; Jessica L. Slack; Sarah M. Estrada; Avedis Kazanjian; Sem Chan; Irina Burd; Peter G. Napolitano; Nicholas Ieronimakis
Preterm infants are at significantly increased risk for lifelong neurodevelopmental disability with male offspring disproportionately affected. Corticosteroids (such as betamethasone) and magnesium sulphate (MgSO4) are administered to women in preterm labor to reduce neurologic morbidity. Despite widespread use of MgSO4 in clinical practice, its effects on adult offspring are not well known nor have sex-specific differences in therapeutic response been explored. The objective of our study was to examine the long-term effects of perinatal neuroinflammation and the effectiveness of prenatal MgSO4/betamethasone treatments between males and females in a murine model via histologic and expression analyses. Our results demonstrate that male but not female offspring exposed to intrauterine inflammation demonstrated impaired performance in neurodevelopmental testing in early life assessed via negative geotaxis, while those exposed to injury plus treatment fared better. Histologic analysis of adult male brains identified a significant reduction in hippocampal neural density in the injured group compared to controls. Evaluation of key neural markers via qRT-PCR demonstrated more profound differences in gene expression in adult males exposed to injury and treatment compared to female offspring, which largely showed resistance to injury. Prenatal treatment with MgSO4/betamethasone confers long-term benefits beyond cerebral palsy prevention with sex-specific differences in response.
Placenta | 2018
Luckey C. Reed; Sarah M. Estrada; Robert Walton; Peter G. Napolitano; Nicholas Ieronimakis
BACKGROUND Gestational diabetes affects almost 1 in 10 pregnancies and is associated with adverse outcomes including fetal demise. Pregnancy complications related to diabetes are attributed to placental vascular dysfunction. With diabetes, maternal hyperglycemia is thought to promote placental vasoconstriction. However, it remains poorly understood if and how hyperglycemia leads to placental vascular dysfunction or if humoral factors related to maternal diabetes are responsible. METHODS AND RESULTS Utilizing a human placenta dual cotyledon, dual perfusion assay we examined the arterial pressure response to the thromboxane mimetic U44619, in cotyledons exposed to normal vs. a hyperglycemic infusion into the intervillous space. Tissues were then analyzed for the activity of key signaling molecules related to vascular tone; eNOS, Akt, PKA and VEGFR2. Results indicate a significant increase in fetal vascular resistance with maternal exposure to hyperglycemia. This response corresponded with a reduction in the phosphorylation of eNOS at Ser1177 and Akt at Thr308. In contrast, VEGFR2 at Tyr1175 and PKA at Thr197 were not different with hyperglycemia. CONCLUSION Reductions of eNOS and Akt phosphorylation at key residues implicated in nitric oxide production suggest that hyperglycemia alters the vasodilatory signaling of placental vessels. In contrast, acute hyperglycemic exposure may not alter vasoconstriction via VEGF and PKA signaling. Altogether our results link hyperglycemic exposure in human placentas to nitric oxide signaling; a mechanisms that may account for the elevations in vascular resistance commonly observed in diabetic pregnancies.
Contemporary Clinical Trials | 2018
Diane M. Flynn; Linda H. Eaton; Dale J. Langford; Nicholas Ieronimakis; Honor McQuinn; Richard O. Burney; Samuel L. Holmes; Ardith Z. Doorenbos
Chronic pain is a leading cause of disability among active duty service members in the U.S. armed forces. Standard rehabilitative care and complementary and integrative health therapies are used for chronic pain rehabilitation. However, the optimal sequence and duration of these therapies has yet to be determined. This article describes a sequential multiple assignment randomized trial (SMART) protocol being used to identify the optimal components and sequence of standard rehabilitative care and complementary and integrative health therapies for reducing pain impact and improving other patient outcomes. Active duty service members referred to Madigan Army Medical Center for treatment of chronic pain are being recruited to the Determinants of the Optimal Dose and Sequence of Functional Restoration and Integrative Therapies study. Study participants are randomized to either standard rehabilitative care (physical and occupational therapy and psychoeducation) or complementary and integrative health therapies (chiropractic, acupuncture, yoga and psychoeducation). Those participants who do not respond to the first 3 weeks of treatment are randomized to receive an additional 3 weeks of either (1) the alternative treatment or (2) the first-stage treatment plus the alternative treatment. This study will also determine factors associated with treatment response that can support clinical decision making, such as baseline fitness, pain catastrophizing, kinesiophobia, post-traumatic stress, pain self-efficacy, and biological indicators. The information gained from this research will be applicable to all integrative chronic pain rehabilitation programs throughout the U.S. Department of Defense and the U.S. Department of Veterans Affairs, and the broader rehabilitation community.
Annals of Otology, Rhinology, and Laryngology | 2018
Paul R. Wistermayer; Wesley R. McIlwain; Nicholas Ieronimakis; Derek J. Rogers
Objective: Validate an accurate and reproducible method of measuring the cross-sectional area (CSA) of the upper airway. Subjects and Methods: This is a prospective animal study done at a tertiary care medical treatment facility. Control images were obtained using endotracheal tubes of varying sizes. In vivo images were obtained from various timepoints of a concurrent study on subglottic stenosis. Using a 0° rod telescope, an instrument was placed at the level of interest, and a photo was obtained. Three independent and blinded raters then measured the CSA of the narrowest portion of the airway using open source image analysis software. Results: Each blinded rater measured the CSA of 79 photos. The t testing to assess for accuracy showed no difference between measured and known CSAs of the control images (P = .86), with an average error of 1.5% (SD = 5.5%). All intraclass correlation (ICC) values for intrarater agreement showed excellent agreement (ICC > .75). Interrater reliability among all raters in control (ICC = .975; 95% CI, .817-.995) and in vivo (ICC = .846;, 95% CI, .780-.896) images showed excellent agreement. Conclusions: We validate a simple, accurate, and reproducible method of measuring the CSA of the airway that can be used in a clinical or research setting.
American Journal of Obstetrics and Gynecology | 2018
Diana Villazana-Kretzer; Stacey Stevens Schmiedecke; Peter G. Napolitano; Jennifer Stencel-Baerenwald; Michael Gale; Nicholas Ieronimakis
American Journal of Obstetrics and Gynecology | 2018
Sarah M. Estrada; Andrew S. Thagard; Irina Burd; Peter G. Napolitano; Nicholas Ieronimakis
International Journal of Pediatric Otorhinolaryngology | 2017
Wesley R. McIlwain; Paul R. Wistermayer; Tyler P. Swiss; Shannon T. Marko; Nicholas Ieronimakis; Derek J. Rogers
American Journal of Obstetrics and Gynecology | 2017
Sarah M. Estrada; Andrew S. Thagard; Irina Burd; Peter G. Napolitano; Nicholas Ieronimakis
American Journal of Obstetrics and Gynecology | 2017
Robert Walton; Nicholas Ieronimakis; Luckey C. Reed; Sarah M. Estrada; Peter G. Napolitano
American Journal of Obstetrics and Gynecology | 2017
Luckey C. Reed; Robert Walton; Sarah M. Estrada; Peter G. Napolitano; Nicholas Ieronimakis